Updates in Immunotherapy for Pancreatic Cancer

被引:0
|
作者
Chick, Robert Connor [1 ]
Pawlik, Timothy M. [1 ]
机构
[1] Ohio State Univ, Dept Surg, Wexner Med Ctr, Columbus, OH 43210 USA
关键词
pancreatic cancer; immunotherapy; personalized; tumor microenvironment; immune checkpoint inhibitor; cancer vaccine; T-CELLS; TUMOR MICROENVIRONMENT; CHECKPOINT INHIBITORS; STROMAL INFLAMMATION; NEOADJUVANT THERAPY; OPEN-LABEL; COMBINATION; TRIAL; PEMBROLIZUMAB; FOLFIRINOX;
D O I
10.3390/jcm13216419
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy with limited effective therapeutic options. Due to a variety of cancer cell-intrinsic factors, including KRAS mutations, chemokine production, and other mechanisms that elicit a dysregulated host immune response, PDAC is often characterized by poor immune infiltration and an immune-privileged fibrotic stroma. As understanding of the tumor microenvironment (TME) evolves, novel therapies are being developed to target immunosuppressive mechanisms. Immune checkpoint inhibitors have limited efficacy when used alone or with radiation. Combinations of immune therapies, along with chemotherapy or chemoradiation, have demonstrated promise in preclinical and early clinical trials. Despite dismal response rates for immunotherapy for metastatic PDAC, response rates with neoadjuvant immunotherapy are somewhat encouraging, suggesting that incorporation of immunotherapy in the treatment of PDAC should be earlier in the disease course. Precision therapy for PDAC may be informed by advances in transcriptomic sequencing that can identify immunophenotypes, allowing for more appropriate treatment selection for each individual patient. Personalized and antigen-specific therapies are an increasing topic of interest, including adjuvant immunotherapy using personalized mRNA vaccines to prevent recurrence. Further development of personalized immune therapies will need to balance precision with generalizability and cost.
引用
收藏
页数:18
相关论文
共 50 条
  • [31] Immunotherapy for pancreatic cancer:: current concepts
    Kaufman, HL
    Di Vito, J
    Hörig, H
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2002, 16 (01) : 159 - +
  • [32] Immunotherapy for pancreatic cancer: A 2020 update
    Schizas, Dimitrios
    Charalampakis, Nikolaos
    Kole, Christo
    Economopoulou, Panagiota
    Koustas, Evangelos
    Gkotsis, Efthymios
    Ziogas, Dimitrios
    Psyrri, Amanda
    Karamouzis, Michalis, V
    CANCER TREATMENT REVIEWS, 2020, 86
  • [33] Exosomes and the Future of Immunotherapy in Pancreatic Cancer
    Batista, Ines A.
    Melo, Sonia A.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (03)
  • [34] Harnessing the Microbiome for Pancreatic Cancer Immunotherapy
    Vitiello, Gerardo A.
    Cohen, Deirdre J.
    Miller, George
    TRENDS IN CANCER, 2019, 5 (11): : 670 - 676
  • [35] Emerging trends in the immunotherapy of pancreatic cancer
    Banerjee, Kasturi
    Kumar, Sushil
    Ross, Kathleen A.
    Gautam, Shailendra
    Poelaert, Brittany
    Nasser, Mohd Wasim
    Aithal, Abhijit
    Bhatia, Rakesh
    Wannemuehler, Michael J.
    Narasimhan, Balaji
    Solheim, Joyce C.
    Batra, Surinder K.
    Jain, Maneesh
    CANCER LETTERS, 2018, 417 : 35 - 46
  • [36] Trials and tribulations of pancreatic cancer immunotherapy
    Principe, Daniel R.
    Korc, Murray
    Kamath, Suneel D.
    Munshi, Hidayatullah G.
    Rana, Ajay
    CANCER LETTERS, 2021, 504 : 1 - 14
  • [37] Advances in Immunotherapy for Pancreatic Cancer: 2013
    DeVito, Nicholas C.
    Saif, Muhammad Wasif
    JOURNAL OF THE PANCREAS, 2013, 14 (04): : 347 - 353
  • [38] Challenges and Opportunities for Pancreatic Cancer Immunotherapy
    Bear, Adham S.
    Vonderheide, Robert H.
    O'Hara, Mark H.
    CANCER CELL, 2020, 38 (06) : 788 - 802
  • [39] Immunotherapy for pancreatic cancer: Barriers and breakthroughs
    Torphy, Robert J.
    Zhu, Yuwen
    Schulick, Richard D.
    ANNALS OF GASTROENTEROLOGICAL SURGERY, 2018, 2 (04): : 274 - 281
  • [40] Pancreatic cancer immunotherapy: coming of age
    Muqbil, Irfana
    Mohammad, Ramzi M.
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S675 - S679